Literature DB >> 22325332

Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease.

C-T Huang1, Y-J Tsai, H-D Wu, J-Y Wang, C-J Yu, L-N Lee, P-C Yang.   

Abstract

OBJECTIVE: Although chronic obstructive pulmonary disease (COPD) is a common form of structural lung disease associated with pulmonary non-tuberculous mycobacteria (NTM) infection, no longitudinal studies have investigated the role of NTM in COPD disease progression.
DESIGN: From 2000 to 2008, spirometry-confirmed COPD patients with sputum specimens sent for mycobacterial cultures were included. Analysis of clinical, microbiological and pulmonary function data was performed.
RESULTS: The 251 patients were divided into three groups according to the number of NTM isolates: multiple (n = 47), single (n = 63), and no (n = 141) isolates. Mycobacterium avium complex was the most common species in multiple isolates (36.2%) and single isolate (28.6%) groups. Overall, 24.7% of COPD patients had been admitted for exacerbations at least once a year, and patients with multiple and single NTM isolates were more than twice as likely as those with no isolate to experience such exacerbations (38.3% vs. 31.7% vs. 17.0%). After controlling for confounders, patients with multiple NTM isolates had a greater decline in forced expiratory volume in one second than those with single or no isolates (-79.4 ± 32.8 ml vs. -61.6 ± 31.9 ml and -56.2 ± 31.5 ml).
CONCLUSION: This study suggests that NTM may play a role in disease progression and deterioration of pulmonary function in COPD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22325332     DOI: 10.5588/ijtld.11.0412

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  18 in total

1.  Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.

Authors:  T Tsukatani; H Suenaga; M Shiga; T Ikegami; M Ishiyama; T Ezoe; K Matsumoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-15       Impact factor: 3.267

2.  Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease.

Authors:  Ji Young Hong; Sang A Lee; Song Yee Kim; Kyung Soo Chung; Sung Woo Moon; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Young Ae Kang
Journal:  Qual Life Res       Date:  2014-06-08       Impact factor: 4.147

3.  Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Authors:  R O Pinheiro; E B de Oliveira; G Dos Santos; G M Sperandio da Silva; B J de Andrade Silva; R M B Teles; A Milagres; E N Sarno; M P Dalcolmo; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

4.  Nontuberculosis mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study.

Authors:  Jun-Jun Yeh; Yu-Chiao Wang; Fung-Chang Sung; Christine Yi-Ting Chou; Chia-Hung Kao
Journal:  Lung       Date:  2014-04-02       Impact factor: 2.584

Review 5.  Avian Mycobacteriosis: Still Existing Threat to Humans.

Authors:  Michal Slany; Vit Ulmann; Iva Slana
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

Review 6.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

7.  Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis.

Authors:  Meng-Heng Hsieh; Chun-Yu Lin; Chen-Yu Wang; Yueh-Fu Fang; Yu-Lun Lo; Shu-Min Lin; Horng-Chyuan Lin
Journal:  Infect Drug Resist       Date:  2018-08-10       Impact factor: 4.003

8.  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease.

Authors:  Meng-Rui Lee; Ching-Yao Yang; Kai-Ping Chang; Li-Ta Keng; David Hung-Tsang Yen; Jann-Yuan Wang; Huey-Dong Wu; Li-Na Lee; Chong-Jen Yu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

9.  Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports.

Authors:  Maura J Donohue
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

10.  Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany.

Authors:  R Diel; M Obradovic; S Tyler; J Engelhard; K Kostev
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.